Orion and Bayer have announced the completion of the rolling submission of an NDA for darolutamide. More: Darolutamide’s FDA rolling submission completed Source: News
read moreA novel experimental drug could offer hope for restoring damaged brain cells in Parkinson’s patients. More: Experimental Parkinson’s therapy shows promise Source: News
read moreThe MHRA has given Nuformix approval to commence human pharmacokinetics studies with NXP001 to further assess its potential for chemotherapy-induced nausea and vomiting. More: MHRA gives Nuformix’ NXP001 studies the go-ahead Source: News
read moreA new study has found that information being provided to patients about their rights under the Mental Health Act has improved. More: Mental health information provided to patients improving, study finds Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals